Nicholas A Poan Net Worth

The estimated Net Worth of Nicholas A Poan is at least $443 Mille dollars as of 29 August 2013. Nicholas Poan owns over 6,300 units of Global X Funds stock worth over $289,966 and over the last 19 years Nicholas sold AIQ stock worth over $152,838.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Nicholas Poan AIQ stock SEC Form 4 insiders trading

Nicholas has made over 1 trades of the Global X Funds stock since 2013, according to the Form 4 filled with the SEC. Most recently Nicholas sold 6,300 units of AIQ stock worth $152,838 on 29 August 2013.

The largest trade Nicholas's ever made was selling 6,300 units of Global X Funds stock on 29 August 2013 worth over $152,838. On average, Nicholas trades about 788 units every 0 days since 2006. As of 29 August 2013 Nicholas still owns at least 8,366 units of Global X Funds stock.

You can see the complete history of Nicholas Poan stock trades at the bottom of the page.

What's Nicholas Poan's mailing address?

Nicholas's mailing address filed with the SEC is 1900 S STATE COLLEGE BLVD, SUITE 600, ANAHEIM, CA, 92806.

Insiders trading at Global X Funds

Over the last 21 years, insiders at Global X Funds have traded over $406,216,779 worth of Global X Funds stock and bought 11,973,300 units worth $47,156,496 . The most active insiders traders include Henry R Kravis, James H Jr Greene e Alexandar Jrraether Paul Er.... On average, Global X Funds executives and independent directors trade stock every 92 days with the average trade being worth of $57,648,557. The most recent stock trade was executed by Rhonda A Longmore Grund on 19 May 2016, trading 2,500 units of AIQ stock currently worth $18,975.

What does Global X Funds do?

Complete history of Nicholas Poan stock trades at Global X Funds

Global X Funds executives and stock owners

Global X Funds executives and other stock owners filed with the SEC include:

• R Brian Hanson,
  Executive VP & CFO
• Russell D Jr Phillips,
  EVP, Gen.Coun.,Secre.
• Henry R Kravis,
  Director
• Kenneth S Ord,
  Executive VP & CFO
• Rhonda A Longmore Grund,
  EVP and CFO
• Heping Feng,
  
• Tao L. Zhang,
  
• Edward L Samek,
  Director
• Richard A. Jones,
  Executive Vice President
• Neil F Dimick,
  Director
• Paul S Viviano,
  Chairman, President & CEO
• Richard W Johns,
  EVP, General Counsel & Sec.
• Percy C Jr Tomlinson,
  President & CEO
• Gregory E. Spurlock,
  President. Alliance Oncology
• Christianna S Rosow,
  Principal Accounting Officer
• Scott A Bartos,
  Director
• Larry C. Buckelew,
  Director
• Howard K Aihara,
  VP & Corporate Controller
• Deborah Rodriguez,
  EVP, Human Resources
• Michael J Shea,
  Chief Operating Officer
• Nicholas A Poan,
  VP, Corporate Controller
• Eli H Glovinsky,
  Exec.VP,Gen.Coun,Corp.Secre.
• Michael F Frisch,
  Executive Vice President & COO
• Richard J Hall,
  President, Alliance Oncology
• Curtis Lane,
  Director
• Christopher J Joyce,
  Executive Vice President, M&A
• Aaron Bendikson,
  Director
• Health Investors Ii, Lp All...,
  
• Anthony B Helfet,
  Director
• Principal Opportunities Fun...,
  
• Michael P Harmon,
  Director
• Health Investors Ii, Lp All...,
  
• Alexandar Jrraether Paul Er...,
  
• James C Momtazee,
  Director
• Michael W Michelson,
  Director
• Kenneth W/Nj Freeman,
  Director
• 1996 Gp Llckkr Associates 1...,
  
• James H Jr Greene,
  Director
• Adam Clammer,
  Director
• Andrew P Hayek,
  Executive VP & COO